In the present study, we summarize the clinical data from NSCLC patients, which indicate that TOPN level is highly related to the expression of PD‐L1 in NSCLC cells, making TOPN an potential independent biomarker for NSCLC prognosis. The gene discussed is CD274; the disease is non-small cell lung carcinoma.